Active, not recruiting
Study of Safety and Efficacy of Ceritinib in Combination With Nivolumab in Patients With ALK-positive Non-small Cell Lung Cancer
NCT02393625
- Conditions
- ALK-positive NSCLC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
- Locations
-
- Mayo Clinic - Arizona Scottsdale, Arizona, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Massachusetts General Hospital Thoracic Oncolgoy Boston, Massachusetts, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States